30 Participants Needed

Stress Reduction for Heart Disease

AT
Overseen ByAhmed Tawakol, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Massachusetts General Hospital
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests how an 8-week stress reduction program might reduce inflammation in heart disease. It focuses on people with high stress levels, as stress can affect heart health. Participants will either undergo the stress reduction program or join a group that receives no intervention. Those who often feel stressed and are interested in joining might find this trial a good fit. As an unphased trial, it offers a unique opportunity to contribute to understanding the impact of stress reduction on heart health.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that this stress reduction intervention is safe?

Research has shown that mindfulness-based stress reduction (MBSR) is generally safe for most people. In one study, 87% of participants completed the MBSR program, and over 95% remained in the study until it ended, indicating that most found the program manageable. Another study found that MBSR helped reduce feelings of anxiety, depression, and stress. These results suggest that the stress reduction techniques used in the trial are well-tolerated and have been successfully used by people with heart conditions. Overall, evidence indicates that individuals can safely participate in stress reduction programs.12345

Why are researchers excited about this trial?

Researchers are excited about stress reduction techniques for heart disease because they offer a non-invasive and holistic approach to managing the condition. Unlike traditional treatments like medications or surgical interventions, stress reduction focuses on lifestyle changes that can empower patients to take control of their health. This method targets the root cause of stress, which is a significant risk factor for heart disease, potentially offering long-term benefits without the side effects associated with medication. By reducing stress, patients may see improvements in heart health, mood, and overall well-being.

What evidence suggests that stress reduction might be an effective treatment for heart disease?

Research has shown that stress reduction techniques, such as mindfulness-based stress reduction (MBSR), can benefit people with heart disease. Studies have found that MBSR eases anxiety and depression, lowers blood pressure, and improves the overall quality of life for those with heart conditions. In one study, 87% of participants completed the MBSR program, and the benefits persisted over time. Another study suggested that MBSR might help manage risk factors for heart disease, such as high blood pressure and diabetes. This trial will evaluate the effectiveness of an 8-week stress reduction course, provided to participants in the experimental arm, in addressing heart-related issues.13678

Who Is on the Research Team?

AT

Ahmed Tawakol, MD

Principal Investigator

MGH

Are You a Good Fit for This Trial?

This trial is for adults aged 30-65 who feel stressed out or have a stress score over 5. It's not for those with lower stress levels.

Inclusion Criteria

I feel very stressed and am interested in joining.
I am between 30 and 65 years old.

Exclusion Criteria

Your Perceived Stress Scale (PSS) score is less than 6.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Baseline Imaging

Participants undergo baseline Fluorodeoxyglucose-Positron emission tomography / magnetic resonance imaging

1 week
1 visit (in-person)

Treatment

Participants receive an 8-week stress reduction intervention focusing on mindfulness and relaxation techniques

8 weeks
Weekly sessions (in-person or virtual)

Follow-up

Participants return for follow-up imaging and evaluation to assess the intervention's impact

4 weeks
1 visit (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Stress Reduction
Trial Overview The study tests if an 8-week program to reduce stress can decrease inflammation in blood vessels, measured by a special heart scan using PET and FDG.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Stress ReductionExperimental Treatment1 Intervention
Group II: ControlActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Massachusetts General Hospital

Lead Sponsor

Trials
3,066
Recruited
13,430,000+

Published Research Related to This Trial

A systematic review of 18 studies found that Mindfulness Based Stress Reduction (MBSR) therapy significantly improves the conditions of patients with chronic illnesses such as cancer, hypertension, and diabetes.
MBSR offers a promising alternative treatment method that helps patients manage their diseases more effectively, although more research is needed to fully understand its mechanisms and potential adverse effects.
Mindfulness-based stress reduction: a non-pharmacological approach for chronic illnesses.Niazi, AK., Niazi, SK.[2022]
An abbreviated Mindfulness-Based Stress Reduction (MBSR) program consisting of 6 weekly 75-minute sessions can effectively be implemented during staff lunch breaks, making it a practical training option for healthcare providers and clinic staff.
This adapted MBSR program is not only feasible but also well-accepted, suggesting it could enhance the well-being of healthcare workers in a workplace setting.
Mindfulness-Based Stress Reduction for Health Care Staff: Expanding Holistic Nursing Paradigms to the Whole System.Hazlett-Stevens, H.[2021]
Mindfulness-based stress reduction (MBSR) programs have shown potential in reducing stress and improving health outcomes, based on an integrative review of 21 clinical studies.
However, there is a need for more controlled, randomized studies and qualitative research to better understand the effectiveness and implementation of MBSR interventions.
Integrating mindfulness-based stress reduction.Proulx, K.[2019]

Citations

Mindfulness-based stress reduction program in coronary ...Conclusion: The MBSR program is effective in reducing symptoms of anxiety and depression, perceived stress, BP and BMI in patients with CHD.
Effectiveness of mindfulness-based stress reduction ...The MBSR program led to a stable improvement of the scores of self-efficacy and quality of life of cardiovascular patients. Abstract. Introduction.
Women, Stress and Heart Health: Mindfulness-Based ...In cardiovascular disease, MBSR may be helpful for controlling several risk factors for coronary heart disease such as hypertension, type 2 diabetes mellitus, ...
Randomized Trial of Mindfulness-Based Stress Reduction ...87% of MBSR patients completed the intervention; study retention was >95% at each follow-up visit. At 3 months, compared to controls, MBSR ...
Effect of mindfulness-based interventions on anxiety, ...This study aims to quantify the effect of mindfulness-based interventions (MBIs) on anxiety, depression and stress in CAD patients.
The Utilization and Potential of Mindfulness-Based Stress ...This article primarily focuses on applying mindfulness-based stress reduction in PCI patients with coronary heart disease and its future prospects.
Effect and Acceptability of Mindfulness-Based Stress ...Our meta-analyses did not find a significant reduction in out-of-office BP after MBSR. MBSR reduced depressive, anxiety, and stress symptoms.
Effect of a Brief Mindfulness-Based Program on Stress in ...This randomized clinical trial found that a brief course of mindfulness training during work hours was feasible and effective in reducing stress ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security